India 'at forefront' in fighting COVID-19; 'stands out' in vaccine policy, says IMF's Gita Gopinath
Gopinath lauded India for playing a key role during the crisis by producing and dispatching the coronavirus vaccines to several countries
- Mar 9, 2021,
- Updated Mar 9, 2021 9:54 AM IST
India has been at the vanguard in combatting the COVID-19 pandemic and "really stands out" in terms of its vaccine policy, International Monetary Fund (IMF) Chief Economist Gita Gopinath said on Monday.
Gopinath lauded the country for playing a key role during the crisis by producing and dispatching the coronavirus vaccines to several countries. The IMF chief made the remarks during an interactive session at the inaugural Dr. Hansa Mehta Lecture organised on the occasion of International Women's Day.
"I also want to mention that India really stands out in terms of its vaccine policy. If you look at where exactly is one manufacturing hub for vaccines in the world - that will be India," Gopinath said. She also praised the Serum Institute of India (SII) for manufacturing the most number of vaccines in the world in a regular year, adding that the pharma giant has been producing the coronavirus vaccine doses that are delivered to COVAX and then distributed to countries around the world.
(With inputs from PTI.)
India has been at the vanguard in combatting the COVID-19 pandemic and "really stands out" in terms of its vaccine policy, International Monetary Fund (IMF) Chief Economist Gita Gopinath said on Monday.
Gopinath lauded the country for playing a key role during the crisis by producing and dispatching the coronavirus vaccines to several countries. The IMF chief made the remarks during an interactive session at the inaugural Dr. Hansa Mehta Lecture organised on the occasion of International Women's Day.
"I also want to mention that India really stands out in terms of its vaccine policy. If you look at where exactly is one manufacturing hub for vaccines in the world - that will be India," Gopinath said. She also praised the Serum Institute of India (SII) for manufacturing the most number of vaccines in the world in a regular year, adding that the pharma giant has been producing the coronavirus vaccine doses that are delivered to COVAX and then distributed to countries around the world.
(With inputs from PTI.)